Predictors of response in a sample of treatment-resistant psychotic patients on clozapine

European Archives of Psychiatry and Clinical Neuroscience

Volumn 254, Issue 5, 2004, Pages 343-346

  Ciapparelli, Antonio ^b   Ducci, Francesca ^b   Carmassi, Claudia ^b   Carlini, Marina ^b   Paggini, Rosemma ^b   Catena, Mario ^b   Bottai, Matteo ^a   Dell'Osso, Liliana ^b  

^a Institute for Science and Technology of Information   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

Clozapine; Predictor of response; Psychotic bipolar disorder; Schizoaffective disorder; Schizophrenia

Indexed keywords

CLOZAPINE;

ADULT; ARTICLE; BIPOLAR DISORDER; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG RESPONSE; EDUCATION; FEMALE; GENDER; GLOBAL ASSESSMENT OF FUNCTIONING SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PREDICTION; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; PSYCHOSIS; RATING SCALE; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; TREATMENT OUTCOME;

AGE OF ONSET; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; CLOZAPINE; CROSS-OVER STUDIES; DEMOGRAPHY; EDUCATIONAL STATUS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; OUTCOME ASSESSMENT (HEALTH CARE); PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SCHIZOPHRENIA; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 4744371082     PISSN: 09401334     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00406-004-0511-4     Document Type: Article

References (33)

1. American Psychiatric Association (1987) Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised. Washington, D.C.: American Psychiatric Association
2. Angermeyer MC, Kuhn L, Goldstein JM (1990) Gender and the course of schizophrenia: differences in treated outcomes. Schizophr Bull 16(2):293-307
3. Banov MD, Zarate CA, Tohen M, Scialabba D, Wines JD, Kolbrener M, Kim JW, Cole JO (1994) Clozapine therapy in refractory affective disorders: polarity predicts response in long-term follow-up. J Clin Psychiatry 55(7):295-300
4. Battegay R, Cotar B, Fleischhauer J, Rauchfleisch U (1977) Result and side effects of treatment with clozapine (Leponex R). Compr Psychiatry 18:423-438
5. Bottlender R, Sato T, Jager M, Groll C, Srauss A, Moller HJ (2002) The impact of duration of untreated psychosis and premorbid functioning on outcome of first inpatient treatment in schizophrenic and schizoaffective patients. Eur Arch Psychiatry Clin Neurosci 252(5):226-231
6. Buchanan RW, Breier A, Kirkpatrick B, Ball P, Carpenter WT Jr (1998) Positive and negative symptom response to clozapine in schizophrenic patients with and without the deficit syndrome. Am J Psychiatry 155:751-760
7. Calabrese JR, Kimmel SE, Woyshville MJ, Rapport DJ, Faust CJ, Thompson PA, Meltzer HY (1996) Clozapine for treatment-refractory mania. Am J Psychiatry 153:759-764
8. Cassano GB, Ciapparelli A, Villa M (1997) Clozapine as a treatment tool: only in resistant schizophrenic patients? Eur Psychiatry 12 (suppl 5):347-351
9. Ciapparelli A, Dell'Osso L, Bandettini di Poggio A, Carmassi C, Cecconi D, Fenzi M, Chiavacci MC, Bottai M, Ramacciotti C, Cassano GB (2003) Clozapine in treatment-resistant patients with schizophrenia, schizoaffective, and psychotic bipolar disorder: a naturalistic 48-month follow-up study. J Clin Psychiatry 64:451-458
10. Cox DR (1972) Regression models and life tables (with discussion). J Royal Statistical Society Ser B 34:187-220
11. Fanton WS, Lee B (1993) Can clozapine response be predicted? A naturalistic pilot study. J Nerv Ment Dis 181(1):62-64
12. Gitlin MJ, Swendsen J, Heller TL, Hammen C (1995) Relapse and impairment in bipolar disorder. Am J Psychiatry 152:1635-1640
13. Jones SH, Thormicroft G, Coffey M, Dunn G (1995) A brief mental health outcome scale. Reliability and validity of the Global Assessment of Functioning (GAF). Br J Pychiatry 166:654
14. Kane JM, Honigfeld G, Singer J, Meltzer H (1988) Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine. Arch Gen Psychiatry 45:789-796
15. Lieberman J, Kane JM, Safferman AZ, Pollack S, Howard A, Szymanski S, Masiar SJ, Kronig MH, Cooper T, Novacenko H (1994 a) Predictor of response to clozapine. J Clin Psychiatry 55 (suppl B)9:126128
16. Lieberman JA, Safferman AZ, Pollack S, Szymanski S, Johns C, Howard A, Kronig M, Bookstain P, Kane JM (1994 b) Clinical Effects of Clozapine in Chronic Schizophrenia: Response to treatment and predictor of outcome. Am J Psychiatry 151:1744-1752
17. Loebel AD, Lieberman JA, Alvir JM, Mayerhoff DI, Geisler SH, Szymanski SR (1992) Duration of psychosis and outcome in first-episode schizophrenia. Am J Psychiatry 149(9):1183-1188
18. Marder S, Van Putten T (1988) Who should receive clozapine? Arch Gen Psychiatry 45:865-876
19. McElroy SL, Dessain EC, Pope HG, Cole JO, Keck PE Jr, Frankenberg FR, Aizley HG, O'Brien S (1991) Clozapine in the treatment of psychotic mood disorders, schizoaffective disorder, and schizophrenia. J Clin Psychiatry 52:411-414
20. Meltzer HY, Bastani B, Young Known K, Ramirez LF, Burnett S, Sharpe J (1989) A prospective study of clozapine in treatment-resistent schizophrenic patients. Psychopharmacology 99 (suppl):S68-S72
21. Overall JE, Gorham DR (1962) The Brief Psychiatric Rating Scale. Psychol Rep 10:799-812
22. Pickar D, Owen RR, Litman RE, Konicki PE, Gutierrez R, Rapaport MH (1992) Clinical and Biologic Response to Clozapine in patients with Schizophrenia. Arch Gen Psychiatry 9:345-352
23. Pickar D, Owen RR, Litman RE, Hsiao JK, Su TP (1994) Predictors of Clozapine Response in Schizophrenia. J Clin Psychiatry 55:129-132
24. Rosenheck R, Lawson W, Cryton J Cramer J, Xu W, Thomas J, Stolar M, Charney D (1998) Predictors of differential response to clozapine and haloperidol. Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia. Biol Psychiatry 44:475-482
25. Seeman MV (1982) Gender differences in schizophrenia. Can J Psychiatry 27(2):107-112
26. Seeman MV (1986) Current outcome in schizophrenia: women vs men. Acta Psychiatr Scand 73:609-617
27. Serretti A, Rietschel M, Lattuada E, Krauss H, Schultze TG, Muller DJ, Maier W, Smeraldi E (2001) Major psychoses symptomatology; factor analysis of 2241 psychotic subjects. Eur Arch Psychiatry Clin Neurosci 251(4):193-198
28. Suppes T, Webb A, Paul B (1999) Clinical outcome in 1-year trial of clozapine versus treatment as usual for patients with treatment-resistent illness and history of mania. Am J Psychiatry 156:1164-1169
29. Szymanski S, Lieberman JA, Alvir JM, Mayerhoff D, Loebel A, Geisler S, Chakos M, Koreen A, Jody D, Kane J (1995) Gender differences in onset of illness, treatment response, course, and biologic indexes in first-episode schizophrenic patients. Am J Psychiatry 152(5):698-703
30. Umbricht DS, Wirshing WC, Wirshing DA, McMeniman M, Schooler NR, Marder SR, Kane JM (2002) Clinical predictors of response to clozapine treatment in ambulatory patients with schizophrenia. J Clin Psychiatry 63:420-424
31. Wyatt RJ (1991) Neuroleptics and the natural course of schizophrenia. Schizophr Bull 17(2):325-351
32. Young CR, Longhurst JG, Bowers MB, Mazure CM (1997) The expanding indications for clozapine. Exp and Clin Psychopharmacol 5(3):216-234
33. Zarate CA, Tohen M, Banov M, Weiss MK, Cole JO (1995) Is clozapine a mood stabilizer? J Clin Psychiatry 56:108-112